Cargando…
FOXC2 augments tumor propagation and metastasis in osteosarcoma
Osteosarcoma is a highly malignant tumor that contains a small subpopulation of tumor-propagating cells (also known as tumor-initiating cells) characterized by drug resistance and high metastatic potential. The molecular mechanism by which tumor-propagating cells promote tumor growth is poorly under...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356590/ https://www.ncbi.nlm.nih.gov/pubmed/27634875 http://dx.doi.org/10.18632/oncotarget.11990 |
_version_ | 1782515868405596160 |
---|---|
author | Gozo, Maricel C. Jia, Dongyu Aspuria, Paul-Joseph Cheon, Dong-Joo Miura, Naoyuki Walts, Ann E. Karlan, Beth Y. Orsulic, Sandra |
author_facet | Gozo, Maricel C. Jia, Dongyu Aspuria, Paul-Joseph Cheon, Dong-Joo Miura, Naoyuki Walts, Ann E. Karlan, Beth Y. Orsulic, Sandra |
author_sort | Gozo, Maricel C. |
collection | PubMed |
description | Osteosarcoma is a highly malignant tumor that contains a small subpopulation of tumor-propagating cells (also known as tumor-initiating cells) characterized by drug resistance and high metastatic potential. The molecular mechanism by which tumor-propagating cells promote tumor growth is poorly understood. Here, we report that the transcription factor forkhead box C2 (FOXC2) is frequently expressed in human osteosarcomas and is important in maintaining osteosarcoma cells in a stem-like state. In osteosarcoma cell lines, we show that anoikis conditions stimulate FOXC2 expression. Downregulation of FOXC2 decreases anchorage-independent growth and invasion in vitro and lung metastasis in vivo, while overexpression of FOXC2 increases tumor propagation in vivo. In osteosarcoma cell lines, we demonstrate that high levels of FOXC2 are associated with and required for the expression of osteosarcoma tumor-propagating cell markers. In FOXC2 knockdown cell lines, we show that CXCR4, a downstream target of FOXC2, can restore osteosarcoma cell invasiveness and metastasis to the lung. |
format | Online Article Text |
id | pubmed-5356590 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-53565902017-03-24 FOXC2 augments tumor propagation and metastasis in osteosarcoma Gozo, Maricel C. Jia, Dongyu Aspuria, Paul-Joseph Cheon, Dong-Joo Miura, Naoyuki Walts, Ann E. Karlan, Beth Y. Orsulic, Sandra Oncotarget Research Paper Osteosarcoma is a highly malignant tumor that contains a small subpopulation of tumor-propagating cells (also known as tumor-initiating cells) characterized by drug resistance and high metastatic potential. The molecular mechanism by which tumor-propagating cells promote tumor growth is poorly understood. Here, we report that the transcription factor forkhead box C2 (FOXC2) is frequently expressed in human osteosarcomas and is important in maintaining osteosarcoma cells in a stem-like state. In osteosarcoma cell lines, we show that anoikis conditions stimulate FOXC2 expression. Downregulation of FOXC2 decreases anchorage-independent growth and invasion in vitro and lung metastasis in vivo, while overexpression of FOXC2 increases tumor propagation in vivo. In osteosarcoma cell lines, we demonstrate that high levels of FOXC2 are associated with and required for the expression of osteosarcoma tumor-propagating cell markers. In FOXC2 knockdown cell lines, we show that CXCR4, a downstream target of FOXC2, can restore osteosarcoma cell invasiveness and metastasis to the lung. Impact Journals LLC 2016-09-13 /pmc/articles/PMC5356590/ /pubmed/27634875 http://dx.doi.org/10.18632/oncotarget.11990 Text en Copyright: © 2016 Gozo et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Gozo, Maricel C. Jia, Dongyu Aspuria, Paul-Joseph Cheon, Dong-Joo Miura, Naoyuki Walts, Ann E. Karlan, Beth Y. Orsulic, Sandra FOXC2 augments tumor propagation and metastasis in osteosarcoma |
title | FOXC2 augments tumor propagation and metastasis in osteosarcoma |
title_full | FOXC2 augments tumor propagation and metastasis in osteosarcoma |
title_fullStr | FOXC2 augments tumor propagation and metastasis in osteosarcoma |
title_full_unstemmed | FOXC2 augments tumor propagation and metastasis in osteosarcoma |
title_short | FOXC2 augments tumor propagation and metastasis in osteosarcoma |
title_sort | foxc2 augments tumor propagation and metastasis in osteosarcoma |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356590/ https://www.ncbi.nlm.nih.gov/pubmed/27634875 http://dx.doi.org/10.18632/oncotarget.11990 |
work_keys_str_mv | AT gozomaricelc foxc2augmentstumorpropagationandmetastasisinosteosarcoma AT jiadongyu foxc2augmentstumorpropagationandmetastasisinosteosarcoma AT aspuriapauljoseph foxc2augmentstumorpropagationandmetastasisinosteosarcoma AT cheondongjoo foxc2augmentstumorpropagationandmetastasisinosteosarcoma AT miuranaoyuki foxc2augmentstumorpropagationandmetastasisinosteosarcoma AT waltsanne foxc2augmentstumorpropagationandmetastasisinosteosarcoma AT karlanbethy foxc2augmentstumorpropagationandmetastasisinosteosarcoma AT orsulicsandra foxc2augmentstumorpropagationandmetastasisinosteosarcoma |